February 28, 2017 / 8:20 AM / 6 months ago

BRIEF-Karessa Pharma Q4 operating loss narrows to SEK 2.9 million

Feb 28 (Reuters) - Karessa Pharma Holding AB (publ):

* Q4 operating loss 2.9 million Swedish crowns ($320,637) versus loss 3.2 million crowns year ago

* Q4 pre-tax loss 2.8 million Swedish crowns versus loss 3.2 million crowns year ago Source text for Eikon: Further company coverage: ($1 = 9.0445 Swedish crowns) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below